Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 12—December 2018

Genomic Characterization of β-Glucuronidase–Positive Escherichia coli O157:H7 Producing Stx2a

Yoshitoshi OguraComments to Author , Kazuko Seto, Yo Morimoto, Keiji Nakamura, Mitsuhiko P. Sato, Yasuhiro Gotoh, Takehiko Itoh, Atsushi Toyoda, Makoto Ohnishi, and Tetsuya Hayashi
Author affiliations: Kyushu University, Fukuoka, Japan (Y. Ogura, K. Nakamura, M.P. Sato, Y. Gotoh, T. Hayashi); Osaka Institute of Public Health, Osaka, Japan (K. Seto); Hokkaido Institute of Public Health, Hokkaido, Japan (Y. Morimoto); Tokyo Institute of Technology, Tokyo, Japan (T. Itoh); National Institute of Genetics, Shizuoka, Japan (A. Toyoda); National Institute of Infectious Diseases, Tokyo (M. Ohnishi)

Cite This Article


Among Shiga toxin (Stx)–producing Escherichia coli (STEC) O157:H7 strains, those producing Stx2a cause more severe diseases. Atypical STEC O157:H7 strains showing a β-glucuronidase–positive phenotype (GP STEC O157:H7) have rarely been isolated from humans, mostly from persons with asymptomatic or mild infections; Stx2a-producing strains have not been reported. We isolated, from a patient with bloody diarrhea, a GP STEC O157:H7 strain (PV15-279) that produces Stx2a in addition to Stx1a and Stx2c. Genomic comparison with other STEC O157 strains revealed that PV15-279 recently emerged from the stx1a/stx2c-positive GP STEC O157:H7 clone circulating in Japan. Major virulence genes are shared between typical (β-glucuronidase–negative) and GP STEC O157:H7 strains, and the Stx2-producing ability of PV15-279 is comparable to that of typical STEC O157:H7 strains; therefore, PV15-279 presents a virulence potential similar to that of typical STEC O157:H7. This study reveals the importance of GP O157:H7 as a source of highly pathogenic STEC clones.

Shiga toxin (Stx)–producing Escherichia coli (STEC) with the serotype O157:H7 is characterized by the possession of stx gene(s), the locus of enterocyte effacement (LEE) –encoded type 3 secretion system (T3SS), and a large virulence plasmid (pO157) that encodes enterohemolysin and other virulence factors, such as catalase-peroxidase KatP, a type II secretion system, and the protease EspP (1). Non–sorbitol-fermenting (NSF) and β-glucuronidase–negative (GN) STEC O157:H7 (hereafter referred to as typical STEC O157:H7), the major clone among currently circulating STEC O157:H7 strains, frequently causes large outbreaks of severe enteric infections, including diarrhea, hemorrhagic colitis, and hemolytic uremic syndrome. Stxs are classified as Stx1 or Stx2; Stx1 currently includes 3 subtypes (stx1a, stx1c, and stx1d) and Stx2 includes 7 subtypes (stx2a to stx2g) (2). The stx genes are encoded by lambda-like phages and have been acquired by STEC strains through phage transduction (3). Typical STEC O157:H7 produces Stx1a, Stx2a, and Stx2c, either alone or in combination. Stx2a-producing strains cause more severe infections than do Stx1a-producing strains (4). In addition, the levels of Stx2 production among the STEC O157:H7 strains carrying stx2c, but not stx2a, are typically very low (57).

Figure 1

Thumbnail of Schematic illustrating model of the stepwise evolution of STEC O157. The proposed stepwise evolution model of STEC O157 was schematically illustrated according to previous reports (8,9). Clonal complexes (CCs) A1 to A6 are indicated, along with phenotypic changes, antigen shifts, and acquisitions of Stx phages and pO157. Squares indicate contemporary circulating STEC O157 clones. EPEC, enteropathogenic E. coli; GP, β-glucuronidase–positive; NSF, non–sorbitol-fermenting; SF, sorbitol

Figure 1. Schematic illustrating model of the stepwise evolution of STEC O157. The proposed stepwise evolution model of STEC O157 was schematically illustrated according to previous reports (8,9). Clonal...

According to the stepwise evolution model (8,9), STEC O157:H7 evolved from ancestral enteropathogenic E. coli (EPEC) O55:H7 (sorbitol-fermenting [SF] and β-glucuronidase–positive [GP]; clonal complex [CC] A1) through sequential acquisitions of virulence factors and phenotypic traits along with a serotype change (Figure 1). Two phenotypic variants of STEC O157 are known: SF/GP STEC O157:H– (nonmotile) (CC A4), known as the German clone (SF STEC O157:H–), and NSF/GP STEC O157:H7 (CC A5) (GP STEC O157:H7). Both variants are postulated to have emerged from a hypothetical intermediate, CC A3; typical STEC O157:H7 (CC A6) has further emerged from CC A5.

SF STEC O157:H– strains are usually stx2a positive (10); like typical STEC O157:H7, they have caused many outbreaks and sporadic cases of hemolytic uremic syndrome in Germany and other countries in Europe. Therefore, this clone is generally thought to be highly pathogenic (1113). In contrast, although GP STEC O157:H7 strains have been reported to carry both stx1 and stx2 or only stx2 (1416), strains producing the Stx2a subtype have not been described. Although GP STEC O157:H7 was first isolated from a patient with bloody diarrhea in 1994 (14), this variant has rarely been isolated from humans. Moreover, human isolates obtained to date have generally been isolated from patients with asymptomatic or mild infections (16). The genomic information available for GP STEC O157:H7 is also limited to strain G5101 (9,17) and 4 strains in public databases. Thus, the virulence potential of GP STEC O157:H7 remains to be fully elucidated.

In this study, we isolated a GP STEC O157:H7 strain that produces Stx2a, in addition to Stx1a and Stx2c, from a patient with bloody diarrhea in Japan and determined its complete genome sequence. To reveal the genomic features of the Stx2a-producing strain, we determined the draft genome sequences of an additional 13 GP STEC O157:H7 isolates, which are all Stx2a negative but Stx1a/Stx2c (or Stx2c) positive, and performed fine phylogenetic and genomic comparisons of these GP STEC O157:H7 strains with typical STEC O157:H7 and SF STEC O157:H– strains. We also analyzed the Stx production levels of GP STEC O157:H7 strains.


Bacterial Strains

The strains used in this study are listed in Technical Appendix Table 1. The GP STEC O157:H7 strain PV15-279 was isolated from an adult patient in Japan who was hospitalized in 2015 with severe symptoms, including bloody diarrhea. The other 13 GP STEC O157:H7 strains sequenced in this study were isolated in Japan during 1988–2013 from humans with or without symptoms. We obtained genome sequence information for 3 E. coli O55:H7 (1820), 2 SF STEC O157:H–, 14 typical STEC O157:H7 (2126), and 2 GP STEC O157:H7 strains (17) from public databases.

Subtyping of stx Genes

We performed in silico subtyping of stx1 and stx2 in all strains analyzed in this study. We used blastn (; >99% identity and >99% coverage) for comparisons with previously reported reference sequences (2).

Genome Sequencing, Assembly, and Annotation

We determined the complete genome sequence of PV15-279 using PacBio reads obtained with an RS II system (PacBio, Menlo Park, CA, USA). We assembled the reads with Canu version 1.5 (27) and circularized them using Circlator (28). We obtained Illumina paired-end reads (300 bp × 2) with a MiSeq sequencer (Illumina, San Diego, CA, USA) and mapped them to the assembly using the Burrows-Wheeler aligner (29) for sequence-error correction with Pilon (30). We completed further corrections to the sequences corresponding to Stx phage regions using MiSeq reads obtained by sequencing long-range PCR products covering each Stx phage. We performed annotations with the DDBJ Fast Annotation and Submission Tool (31), followed by manual curation using the IMC-GE software (In Silico Biology, Kanagawa, Japan).

We obtained the draft genome sequences of 13 GP STEC O157:H7 strains by assembling Illumina paired-end reads using Platanus (32). The Illumina reads for strain LB473017, for which the only read data available were from public databases, were also assembled with Platanus.

The genome sequences of PV15-279 and the 13 GP STEC O157:H7 strains have been deposited in DDBJ/EMBL/GenBank under the Bioproject accession numbers PRJDB6584 and PRJDB6498, respectively. The accession numbers of each sample, including the reference data, are listed in Technical Appendix Table 1.

Single-Nucleotide Polymorphism Detection and Phylogenetic Analysis

We performed single-nucleotide polymorphism (SNP) detection and phylogenetic analyses as described previously (33). The genome sequences to be examined were aligned with the phage- and insertion sequence (IS)–masked chromosome sequence of the STEC O157:H7 strain Sakai (22) using MUMmer (34) to identify conserved regions (cutoff thresholds >98% sequence identity and >1,000-bp alignment length) in each strain and the SNP sites located therein. We then determined the core genome sequence that was conserved in all strains examined. Only SNPs located in the core genome were subjected to further analysis. After reconstructing the genome sequences of each strain using the SNPs and removing recombinogenic SNP sites using Gubbins (35), we constructed a maximum-likelihood phylogenetic tree using RAxML (36) with the general time-reversible plus gamma model of nucleotide substitution and 500 bootstrap replicates. The tree was displayed and annotated using iTOL (37).

Repertoire Analysis of Genes Encoding T3SS Effectors and Plasmid-Encoded Virulence Factors

We analyzed the conservation of genes encoding T3SS effectors and plasmid-encoded virulence factors with blastn (>90% identity and >30% coverage). All intact effector genes and plasmid virulence genes identified in strains Sakai and PV15-279 were clustered using CD-HIT (38) at >90% identity and >30% alignment coverage of the longer sequences, and representative sequences of each cluster were used to create a database for blastn analysis.

Stx Phage Sequencing

We determined the complete sequences of the Stx1a and Stx2c phages from strain 980938 (from an asymptomatic carrier) and the Stx2c phage from strain 981447 (from a patient with bloody diarrhea) as described previously (39). We constructed fosmid libraries of the 2 strains using a CopyControl fosmid library production kit (Epicenter Biotechnologies, Madison, WI, USA). We screened the stx1- or stx2-containing clones using PCR and sequenced them by the shotgun sequencing strategy using an ABI3730 sequencer (Applied Biosystems, Foster City, CA, USA).

Stx Production Assay

We inoculated bacterial cells into 40 mL of CAYE broth (Merck, Darmstadt, Germany) and grew them to mid-log phase at 37°C with shaking. We then added mitomycin C (MMC) to the culture at a final concentration of 500 ng/mL. After MMC addition, we collected 100 μL of the culture every hour and immediately subjected it to sonication using a Bioruptor (Cosmo Bio, Tokyo, Japan). We obtained the soluble fractions of each cell lysate via centrifugation at 14,000 × g for 10 min at 4°C. We determined Stx1 and Stx2 concentrations in each cell lysate using a previously described sandwich ELISA (40). We captured Stx using RIDASCREEN Verotoxin microtiter plates (R-Biopharm, Darmstadt, Germany) coated with capture antibodies that recognize both Stx1 and Stx2. We conjugated monoclonal antibodies against Stx1 and Stx2 (LSBio, Seattle, WA, USA) with horseradish peroxidase using the Peroxidase Labeling Kit–NH2 (Dojindo, Kumamoto, Japan) and employed them as detection antibodies. We used reagents supplied in the RIDASCREEN Verotoxin kit for detection. Finally, we measured the absorbance at 450 nm (A450) using Tecan Infinite 200 PRO (Tecan, Männedorf, Switzerland).


Isolation and Genome Sequencing of GP O157:H7 Strains

In PV15-279, we detected stx2a in addition to stx1a and stx2c (Technical Appendix Table 1). Determination of the complete genome sequence of PV15-279 revealed that the genome consisted of a 5,598,151-bp chromosome and a 94,391-bp plasmid. The draft genome sequences of 13 additional GP STEC O157:H7 strains were also determined for comparison (Technical Appendix Table 1). These strains were all stx1a/stx2c-positive and stx2a-negative. The uidA gene, which encodes β-glucuronidase, was intact in all the GP STEC O157:H7 strains sequenced in this study, as well as in 2 GP STEC O157:H7 strains whose draft genome sequences were publicly available (Technical Appendix Table 1). In typical STEC O157:H7, uidA has been inactivated by a frameshift mutation (41).

Comparisons of General Genomic Features and Mobile Genetic Elements

Although the chromosome of PV15-279 was ≈100 kb larger than that of the typical GP STEC O157:H7 strain Sakai (Table and Technical Appendix Figure 1), the chromosome backbone was highly conserved; 97.2% of the coding sequences (CDSs) identified in Sakai were conserved in PV15-279. Among the various types of mobile genetic elements (MGEs), integrative elements (defined as elements that contain an integrase gene but no other MGE-related genes) were well conserved and showed only minor variations. Among the 5 integrative elements identified in Sakai, 1 small element (SpLE2) was missing in PV15-279, and multiple small structural variations were observed in 3 elements (Technical Appendix Table 2, Figure 2, panel B). In contrast, the prophage contents exhibited notable differences. PV15-279 contained 22 prophages, whereas Sakai contained 18 prophages. This difference is attributable mainly to the difference in chromosome sizes between the 2 strains. Although most of the integration sites used by Sakai prophages (13/16) are also used by PV15-279 prophages (Technical Appendix Table 2, Figure 2, panel A), in most instances prophages that had integrated into the same site showed notable variations between the 2 strains, suggesting the existence of different evolutionary histories. Furthermore, PV15-279 carried as many as 4 Stx phages: 1 Stx1a phage, 2 Stx2a phages, and 1 Stx2c phage (Technical Appendix Figure 1). In contrast, Sakai carries 1 Stx1a phage and 1 Stx2a phage (see subsequent sections for a comparison of these phages with Stx phages from various STEC O157:H7 strains). Surprisingly, 1 of the 2 Stx2a phages (PV15p10) was integrated together with 3 prophages at the ydfJ locus in PV15-279 in tandem (Technical Appendix Table 2, Figure 1, Figure 2, panel A).

The repertoires and total copy numbers of IS elements also exhibited notable differences (Technical Appendix Table 3). Although 24 types of IS elements were identified in Sakai and 18 types were identified in PV15-279, only 14 were shared by the 2 strains. A greater number of total copies of IS elements was detected in PV15-279 (91, compared with 73 in Sakai), primarily because of the proliferation of IS1203 (also annotated as IS629) in PV15-279. The virulence plasmid pO157 also showed notable differences, as described in the next section.

Phylogenetic Characterization of GP STEC O157:H7 Strains

Figure 2

Thumbnail of Whole-genome sequence-based phylogenetic analysis and repertoires of T3SS effectors and plasmid-encoding virulence factors from the study of Stx–producing E. coli O157:H7. The genome sequences of all the strains used in this study were aligned with the complete chromosome sequence of Sakai, and the single-nucleotide polymorphisms located in the 4,074,209-bp backbone sequence that were conserved in all the test strains were identified. After removing the recombinogenic single-nucleot

Figure 2. Whole-genome sequence-based phylogenetic analysis and repertoires of T3SS effectors and plasmid-encoding virulence factors from the study of Stx–producing E. coli O157:H7. The genome sequences of all the strains used in this...

To determine the precise phylogenetic position of PV15-279 in STEC O157, we performed high-resolution phylogenetic analysis using the genome sequences of various typical and atypical STEC O157 strains (Figure 2). The results clearly indicate that PV15-279 formed a distinct cluster with all other GP STEC O157:H7 strains, including 2 US isolates, and is a strain that recently emerged from the stx1a/stx2c-positive clone circulating in Japan. The phylogenetic relationship of this cluster with other STEC O157 lineages was concordant with the stepwise evolution model (Figure 1).

In our phylogenetic tree, the GP STEC O157:H7 strains were relatively clonal compared with the typical STEC O157:H7 strains, although these typical STEC O157:H7 strains were selected to represent their currently known phylogenetic diversity (26) (Figure 2). Despite the close phylogenetic relationship between the GP STEC O157:H7 strains, only PV15-279 was stx2a-positive, indicating that PV15-279 acquired stx2a very recently. No stx genes were detected in the publicly available sequence data for the GP STEC O157:H7 strain G5101, although this strain was previously reported to contain stx1 and stx2 (14).

Distribution of T3SS Effectors in the GP O157:H7 Lineage

In addition to 5 LEE-encoded T3SS effectors, 18 families of effectors are encoded at non-LEE genomic loci (non-LEE effectors) in Sakai (42). In PV15-279, we identified most of the effector families found in Sakai (Technical Appendix Table 4). The major differences were the absence of nleF in PV15-279 and the presence of ospB and ospG in PV15-279, both of which are absent in Sakai. After subgrouping the 4 effector families (espM, espN, espO, and nleG) into 2–5 subgroups based on their sequence diversity, we analyzed the effector repertoires of the STEC O157 isolates used in the phylogenetic analysis (Figure 2). This analysis revealed that the effectors identified in PV15-279 were mostly conserved in other GP STEC O157:H7 strains, although some variations were detected.

Virulence Plasmid pO157 of GP O157:H7 Lineage

The pO157 plasmid of PV15-279 was nearly identical to the plasmid from the GP STEC O157:H7 strain G5101 (43), with several small variations that were apparently generated by mechanisms involving IS (Technical Appendix Figure 3). The plasmid-encoded virulence genes identified in PV15-279 were well conserved in other GP STEC O157:H7 strains, except for 3 strains from which pO157 has apparently been deleted (Figure 2). It is unknown whether this deletion occurred before or after strain isolation.

As previously reported (43), the pO157 plasmids from GP STEC O157:H7 showed high similarity to those from typical STEC O157:H7 and SF STEC O157:H–. Thus, a pO157-like plasmid was likely acquired by the common ancestor of the 3 STEC O157 lineages. A notable difference between the pO157 plasmids of the 3 STEC O157 lineages was the distribution of katP and espP. These genes were detected only in typical STEC O157:H7 strains, suggesting that these genes may have been specifically acquired by the typical STEC O157:H7 lineage. Although the roles of katP and espP in STEC virulence in humans have not yet been elucidated, at least the SF STEC O157:H– strain causes severe infections even without these genes.

Stx Phages of GP STEC O157:H7

Figure 3

Thumbnail of Genome comparisons of Stx phages from the study of Stx–producing E. coli O157:H7. The results of the comparison of the genome structure (right) and dot-plot sequence comparisons (left) of the Stx phages are shown. Sequence identities are indicated by different colors. In the dot-plot matrices, phages integrated in the same integration sites are highlighted by gray shading and colored frames. GP,  β-glucuronidase–positive; IS, insertion sequence.

Figure 3. Genome comparisons of Stx phages from the study of Stx-producing E. coli O157:H7. The results of the comparison of the genome structure (left) and dot-plot sequence comparisons (right) of the Stx...

As shown in Figure 3, we performed fine genomic comparisons of the Stx phages from PV15-279 with the Stx1a, Stx2a, and Stx2c phages from other STEC O157:H7 strains used in the phylogenetic analysis shown in Figure 2 (phages were included only when complete sequences were available). The Stx1a and Stx2c phages of the GP STEC O157:H7 strain 980938 and the Stx2c phage of the GP STEC O157:H7 strain 981447 were sequenced individually and included in the analysis.

Stx1a phages were integrated in sbcB in the 2 GP STEC O157:H7 strains but were integrated in yehV or argW in typical STEC O157:H7 strains. According to the dot plot analysis, the 2 Stx1a phages from GP STEC O157:H7 were nearly identical (Figure 3). The phages from typical STEC O157:H7 strains were classified into 3 groups based on sequence similarity. The Stx1a phages from GP STEC O157:H7 showed various levels of sequence similarity to each group. The highest similarity was observed for the 3 phages integrated in yehV, but a clear difference was observed in the early region.

The 2 Stx2a phages from PV15-279 that integrated in yecE and ydfJ were nearly identical (only 2 SNPs), indicating that these phages were recently duplicated in this strain. With 1 exception (the phage from strain 155), the Stx2a phages from the typical STEC O157:H7 strains analyzed in this study were integrated in either wrbA or argW, and all shared a similar genomic structure, although considerable variations were observed in the early region, as reported previously (7). The Stx2a phages from PV15-279 exhibited a genetic structure similar to that of strain 155, which was also integrated in yecE. However, those phages showed high sequence similarity only in limited regions.

The Stx2c phages from GP STEC O157:H7 strains (all integrated in yehV) were nearly identical, showing only minor variations, such as IS integration. The Stx2c phages from typical STEC O157:H7 strains, which were all integrated in sbcB, also exhibited very similar genomic structures and sequences. Although notable sequence similarity was observed between the Stx2c phages from GP STEC O157:H7 and typical STEC O157:H7, the early regions were very different.

Stx Production by GP STEC O157:H7 Strains

Figure 4

Thumbnail of Lysis curves and levels of Stx produced by STEC O157:H7 strains after MMC treatment in study of Stx–producing E. coli. The lysis curves (A) and levels of Stx1 (B) and Stx2 (C) production by 5 STEC O157:H7 strains after the MMC treatment are shown. After the addition of MMC, the OD600 of each strain was measured every hour for 8 hours, and 100 μL of the culture was collected at each time point. Cell lysates were prepared, and the Stx1 and Stx2 concentrations in the soluble fractions

Figure 4. Lysis curves and levels of Stx produced by STEC O157:H7 strains after MMC treatment in study of Stx-producing E. coli. The lysis curves (A) and levels of Stx1 (B) and Stx2...

Stx1 production is partially dependent on phage induction, whereas Stx2 production is strongly dependent on phage induction (4446). We compared Stx production levels between GP STEC O157:H7 and typical STEC O157:H7 using MMC as a phage induction agent; we analyzed Stx1 and Stx2 production by representative strains of the 2 lineages (PV15-279, 981447, and 980938 for GP STEC O157:H7; Sakai and EDL933 for typical STEC O157:H7). MMC exhibited different levels of effectiveness in phage induction in each strain, and clear cell lysis (a clear reduction in OD600 values) was observed only in EDL933 and PV15-279 (Figure 4, panel A).

Consistent with a previous report (47), the Stx1 concentration was not notably elevated by phage induction in any of the strains, and no clear difference was observed between the GP STEC O157:H7 and typical STEC O157:H7 strains (Figure 4, panel B). In contrast, levels of Stx2 production were highly variable, as previously shown for typical STEC O157:H7 strains (7). Although Stx2 production was poorly induced in 2 GP STEC O157:H7 strains carrying stx2c alone, it was strongly induced in the stx2a-positive PV15-279 and typical STEC O157:H7 strains (Figure 4, panel C). Therefore, stx2a was strongly induced in PV15-279, as in typical STEC O157:H7, but stx2c was poorly induced in PV15-279, as in the other GP STEC O157:H7 strains. The level of Stx2 production by PV15-279 was comparable to that of typical STEC O157:H7 strains and similar to that of the Sakai strain.


In this study, we isolated a GP STEC O157:H7 strain (PV15-279) that produces Stx2a in addition to Stx1a and Stx2c. The whole-genome sequence-based phylogenetic analysis, which included additional GP STEC O157:H7 strains and representative strains belonging to other E. coli O55/O157 lineages, revealed that PV15-279 recently emerged by the acquisition of Stx2a phage from the stx1a/stx2c-positive GP STEC O157:H7 clone circulating in Japan (Figure 2). Most of the major virulence genes identified in typical STEC O157:H7, such as T3SS effector genes and plasmid-encoded virulence genes, were well conserved in PV15-279 and other GP STEC O157:H7 strains, although some variations were detected (Figure 2). Moreover, the ability of PV15-279 to produce Stx2a was comparable to that of typical STEC O157:H7 (Figure 4). These findings suggest that PV15-279 presents a virulence potential similar to that of typical STEC O157:H7. In fact, PV15-279 was isolated from a patient who had severe enteric symptoms, including bloody diarrhea. However, further investigations are necessary to determine how the variations in the virulence gene repertoire detected in the comparison with other STEC O157 lineages affect the potential virulence of GP STEC O157:H7. The repertoires of the minor virulence genes of GP STEC O157:H7 must also be investigated.

We also obtained several noteworthy findings concerning the evolution of GP O157:H7 in this study. For example, fine genomic comparisons of Stx phages revealed that Stx phages differ notably between GP STEC O157:H7 and typical STEC O157:H7 (Figure 3). Although many of these variations may have been generated through extensive recombination with various resident or incoming phages (48), the acquisition of the Stx2a phage by the GP STEC O157:H7 strain PV15-279 was apparently an independent genetic event. The clear differences in the genetic structure, sequence, and integration sites of Stx2c phages between GP and typical STEC O157:H7 may suggest that Stx2c phages were also acquired independently by the 2 lineages after they separated. In contrast, the similar genetic structures and sequences of the pO157 plasmids from GP and typical STEC O157:H7 and SF STEC O157:H– suggest that a pO157-like plasmid might have been acquired by their common ancestor. Although more extensive studies are needed to obtain a complete understanding of these issues, only a limited number of SF STEC O157:H– genome sequences and no complete sequences of the Stx phages of this lineage are currently available. The available genome sequence information of GP STEC O157:H7 is also highly biased toward Japanese isolates.

In conclusion, we isolated a Stx2a-producing GP STEC O157:H7 strain that emerged from the stx1a/stx2c-positive GP STEC O157:H7 clone circulating in Japan; the virulence potential of this isolate is similar to that of typical STEC O157:H7. Researchers should pay more attention to this less commonly reported STEC O157 lineage, particularly the spread of this Stx2a-producing GP STEC O157:H7 clone and the emergence of additional stx2a-positive clones. Larger-scale genomic analyses including more GP STEC O157:H7 strains from various geographic regions and more SF STEC O157:H– strains are required to obtain a better understanding of the evolution and genomic diversity of GP O157:H7.

Dr. Ogura is an associate professor in the department of bacteriology at the Faculty of Medical Sciences, Kyushu University, Kyushu, Japan. His primary research interests include bacterial genomics and pathogenicity.



We thank A. Yoshida, Y. Inoue, M. Shimbara, N. Kanemaru, N. Kawano, N. Sakamoto, H. Iguchi, M. Horiguchi, M. Kumagai, and Y. Morita for providing technical assistance.

This work was funded by the Japan Society for the Promotion of Science (KAKENHI) under grant nos. 16K15278 and 17H04077 to Y.O. and 16H05190 to T.H. and by the Japan Agency for Medical Research and Development under grant nos. JP17efk0108127h0001 to Y.O. and JP17fk0108308j0003 to T.H.



  1. Pennington  H. Escherichia coli O157. Lancet. 2010;376:142835. DOIPubMed
  2. Scheutz  F, Teel  LD, Beutin  L, Piérard  D, Buvens  G, Karch  H, et al. Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx nomenclature. J Clin Microbiol. 2012;50:295163. DOIPubMed
  3. O’Brien  AD, Newland  JW, Miller  SF, Holmes  RK, Smith  HW, Formal  SB. Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea. Science. 1984;226:6946. DOIPubMed
  4. Boerlin  P, McEwen  SA, Boerlin-Petzold  F, Wilson  JB, Johnson  RP, Gyles  CL. Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol. 1999;37:497503.PubMed
  5. de Sablet  T, Bertin  Y, Vareille  M, Girardeau  JP, Garrivier  A, Gobert  AP, et al. Differential expression of stx2 variants in Shiga toxin-producing Escherichia coli belonging to seropathotypes A and C. Microbiology. 2008;154:17686. DOIPubMed
  6. Kawano  K, Okada  M, Haga  T, Maeda  K, Goto  Y. Relationship between pathogenicity for humans and stx genotype in Shiga toxin-producing Escherichia coli serotype O157. Eur J Clin Microbiol Infect Dis. 2008;27:22732. DOIPubMed
  7. Ogura  Y, Mondal  SI, Islam  MR, Mako  T, Arisawa  K, Katsura  K, et al. The Shiga toxin 2 production level in enterohemorrhagic Escherichia coli O157:H7 is correlated with the subtypes of toxin-encoding phage. Sci Rep. 2015;5:16663. DOIPubMed
  8. Feng  PC, Monday  SR, Lacher  DW, Allison  L, Siitonen  A, Keys  C, et al. Genetic diversity among clonal lineages within Escherichia coli O157:H7 stepwise evolutionary model. Emerg Infect Dis. 2007;13:17016. DOIPubMed
  9. Wick  LM, Qi  W, Lacher  DW, Whittam  TS. Evolution of genomic content in the stepwise emergence of Escherichia coli O157:H7. J Bacteriol. 2005;187:178391. DOIPubMed
  10. Karch  H, Bielaszewska  M. Sorbitol-fermenting Shiga toxin-producing Escherichia coli O157:H(-) strains: epidemiology, phenotypic and molecular characteristics, and microbiological diagnosis. J Clin Microbiol. 2001;39:20439. DOIPubMed
  11. Ammon  A, Petersen  LR, Karch  H. A large outbreak of hemolytic uremic syndrome caused by an unusual sorbitol-fermenting strain of Escherichia coli O157:H-. J Infect Dis. 1999;179:12747. DOIPubMed
  12. Karch  H, Böhm  H, Schmidt  H, Gunzer  F, Aleksic  S, Heesemann  J. Clonal structure and pathogenicity of Shiga-like toxin-producing, sorbitol-fermenting Escherichia coli O157:H-. J Clin Microbiol. 1993;31:12005.PubMed
  13. Rosser  T, Dransfield  T, Allison  L, Hanson  M, Holden  N, Evans  J, et al. Pathogenic potential of emergent sorbitol-fermenting Escherichia coli O157:NM. Infect Immun. 2008;76:5598607. DOIPubMed
  14. Hayes  PS, Blom  K, Feng  P, Lewis  J, Strockbine  NA, Swaminathan  B. Isolation and characterization of a beta-D-glucuronidase-producing strain of Escherichia coli serotype O157:H7 in the United States. J Clin Microbiol. 1995;33:33478.PubMed
  15. Nagano  H, Hirochi  T, Fujita  K, Wakamori  Y, Takeshi  K, Yano  S. Phenotypic and genotypic characterization of beta-D-glucuronidase-positive Shiga toxin-producing Escherichia coli O157:H7 isolates from deer. J Med Microbiol. 2004;53:103743. DOIPubMed
  16. Nagano  H, Okui  T, Fujiwara  O, Uchiyama  Y, Tamate  N, Kumada  H, et al. Clonal structure of Shiga toxin (Stx)-producing and beta-D-glucuronidase-positive Escherichia coli O157:H7 strains isolated from outbreaks and sporadic cases in Hokkaido, Japan. J Med Microbiol. 2002;51:40516. DOIPubMed
  17. Rump  LV, Strain  EA, Cao  G, Allard  MW, Fischer  M, Brown  EW, et al. Draft genome sequences of six Escherichia coli isolates from the stepwise model of emergence of Escherichia coli O157:H7. J Bacteriol. 2011;193:20589. DOIPubMed
  18. Hazen  TH, Sahl  JW, Redman  JC, Morris  CR, Daugherty  SC, Chibucos  MC, et al. Draft genome sequences of the diarrheagenic Escherichia coli collection. J Bacteriol. 2012;194:30267. DOIPubMed
  19. Schutz  K, Cowley  LA, Shaaban  S, Carroll  A, McNamara  E, Gally  DL, et al. Evolutionary context of non-sorbitol-fermenting Shiga toxin-producing Escherichia coli O55:H7. Emerg Infect Dis. 2017;23:196673. DOIPubMed
  20. Zhou  Z, Li  X, Liu  B, Beutin  L, Xu  J, Ren  Y, et al. Derivation of Escherichia coli O157:H7 from its O55:H7 precursor. PLoS One. 2010;5:e8700. DOIPubMed
  21. Eppinger  M, Mammel  MK, Leclerc  JE, Ravel  J, Cebula  TA. Genomic anatomy of Escherichia coli O157:H7 outbreaks. Proc Natl Acad Sci U S A. 2011;108:201427. DOIPubMed
  22. Hayashi  T, Makino  K, Ohnishi  M, Kurokawa  K, Ishii  K, Yokoyama  K, et al. Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12. DNA Res. 2001;8:1122. DOIPubMed
  23. Katani  R, Cote  R, Raygoza Garay  JA, Li  L, Arthur  TM, DebRoy  C, et al. Complete genome sequence of SS52, a strain of Escherichia coli O157:H7 recovered from supershedder cattle. Genome Announc. 2015;3:e01569–14. DOIPubMed
  24. Kulasekara  BR, Jacobs  M, Zhou  Y, Wu  Z, Sims  E, Saenphimmachak  C, et al. Analysis of the genome of the Escherichia coli O157:H7 2006 spinach-associated outbreak isolate indicates candidate genes that may enhance virulence. Infect Immun. 2009;77:371321. DOIPubMed
  25. Latif  H, Li  HJ, Charusanti  P, Palsson  BO, Aziz  RKA. A gapless, unambiguous genome squence of the enterohemorrhagic Escherichia coli O157:H7 strain EDL933. Genome Announc. 2014;2:e00821–14. DOIPubMed
  26. Shaaban  S, Cowley  LA, McAteer  SP, Jenkins  C, Dallman  TJ, Bono  JL, et al. Evolution of a zoonotic pathogen: investigating prophage diversity in enterohaemorrhagic Escherichia coli O157 by long-read sequencing. Microb Genom. 2016;2:e000096.PubMed
  27. Koren  S, Walenz  BP, Berlin  K, Miller  JR, Bergman  NH, Phillippy  AM. Canu: scalable and accurate long-read assembly via adaptive k-mer weighting and repeat separation. Genome Res. 2017;27:72236. DOIPubMed
  28. Hunt  M, Silva  ND, Otto  TD, Parkhill  J, Keane  JA, Harris  SR. Circlator: automated circularization of genome assemblies using long sequencing reads. Genome Biol. 2015;16:294. DOIPubMed
  29. Li  H, Durbin  R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:175460. DOIPubMed
  30. Walker  BJ, Abeel  T, Shea  T, Priest  M, Abouelliel  A, Sakthikumar  S, et al. Pilon: an integrated tool for comprehensive microbial variant detection and genome assembly improvement. PLoS One. 2014;9:e112963. DOIPubMed
  31. Tanizawa  Y, Fujisawa  T, Kaminuma  E, Nakamura  Y, Arita  M. DFAST and DAGA: web-based integrated genome annotation tools and resources. Biosci Microbiota Food Health. 2016;35:17384. DOIPubMed
  32. Kajitani  R, Toshimoto  K, Noguchi  H, Toyoda  A, Ogura  Y, Okuno  M, et al. Efficient de novo assembly of highly heterozygous genomes from whole-genome shotgun short reads. Genome Res. 2014;24:138495. DOIPubMed
  33. Ogura  Y, Gotoh  Y, Itoh  T, Sato  MP, Seto  K, Yoshino  S, et al. Population structure of Escherichia coli O26: H11 with recent and repeated stx2 acquisition in multiple lineages. Microb Genom. 2017;3:e000141. DOI
  34. Kurtz  S, Phillippy  A, Delcher  AL, Smoot  M, Shumway  M, Antonescu  C, et al. Versatile and open software for comparing large genomes. Genome Biol. 2004;5:R12. DOIPubMed
  35. Croucher  NJ, Page  AJ, Connor  TR, Delaney  AJ, Keane  JA, Bentley  SD, et al. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins. Nucleic Acids Res. 2015;43:e15. DOIPubMed
  36. Stamatakis  A. RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics. 2006;22:268890. DOIPubMed
  37. Letunic  I, Bork  P. Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees. Nucleic Acids Res. 2016;44(W1):W242-5. DOIPubMed
  38. Li  W, Godzik  A. Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics. 2006;22:16589. DOIPubMed
  39. Ogura  Y, Abe  H, Katsura  K, Kurokawa  K, Asadulghani  M, Iguchi  A, et al. Systematic identification and sequence analysis of the genomic islands of the enteropathogenic Escherichia coli strain B171-8 by the combined use of whole-genome PCR scanning and fosmid mapping. J Bacteriol. 2008;190:694860. DOIPubMed
  40. Ishijima  N, Lee  KI, Kuwahara  T, Nakayama-Imaohji  H, Yoneda  S, Iguchi  A, et al. Identification of a new virulent clade in enterohemorrhagic Escherichia coli O26:H11/H- sequence type 29. Sci Rep. 2017;7:43136. DOIPubMed
  41. Monday  SR, Whittam  TS, Feng  PC. Genetic and evolutionary analysis of mutations in the gusA gene that cause the absence of beta-glucuronidase activity in Escherichia coli O157:H7. J Infect Dis. 2001;184:91821. DOIPubMed
  42. Tobe  T, Beatson  SA, Taniguchi  H, Abe  H, Bailey  CM, Fivian  A, et al. An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination. Proc Natl Acad Sci U S A. 2006;103:149416. DOIPubMed
  43. Rump  LV, Meng  J, Strain  EA, Cao  G, Allard  MW, Gonzalez-Escalona  N. Complete DNA sequence analysis of enterohemorrhagic Escherichia coli plasmid pO157_2 in β-glucuronidase-positive E. coli O157:H7 reveals a novel evolutionary path. J Bacteriol. 2012;194:345763. DOIPubMed
  44. Calderwood  SB, Mekalanos  JJ. Iron regulation of Shiga-like toxin expression in Escherichia coli is mediated by the fur locus. J Bacteriol. 1987;169:475964. DOIPubMed
  45. Tyler  JS, Mills  MJ, Friedman  DI. The operator and early promoter region of the Shiga toxin type 2-encoding bacteriophage 933W and control of toxin expression. J Bacteriol. 2004;186:76709. DOIPubMed
  46. Wagner  PL, Livny  J, Neely  MN, Acheson  DW, Friedman  DI, Waldor  MK. Bacteriophage control of Shiga toxin 1 production and release by Escherichia coli. Mol Microbiol. 2002;44:95770. DOIPubMed
  47. Shimizu  T, Ohta  Y, Noda  M. Shiga toxin 2 is specifically released from bacterial cells by two different mechanisms. Infect Immun. 2009;77:281323. DOIPubMed
  48. Asadulghani  M, Ogura  Y, Ooka  T, Itoh  T, Sawaguchi  A, Iguchi  A, et al. The defective prophage pool of Escherichia coli O157: prophage-prophage interactions potentiate horizontal transfer of virulence determinants. PLoS Pathog. 2009;5:e1000408. DOIPubMed




Cite This Article

DOI: 10.3201/eid2412.180404

Original Publication Date: 11/1/2018

Table of Contents – Volume 24, Number 12—December 2018


Please use the form below to submit correspondence to the authors or contact them at the following address:

Yoshitoshi Ogura, Kyushu University, Department of Bacteriology, Faculty of Medicine Sciences, 3-1-1 Maidashi Higashi-ku, Fukuoka 812-8582, Japan

Send To

character(s) remaining.

Comment submitted successfully, thank you for your feedback.


Page created: November 20, 2018
Page updated: November 20, 2018
Page reviewed: November 20, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.